Gyre Therapeutics (GYRE) Capital Expenditures (2010 - 2026)
Gyre Therapeutics' Capital Expenditures came in at $262,000 for Q2 2026, down 21.8% from $335,000 a year earlier but up 47.2% from the prior quarter.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Capital Expenditures (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Gyre Therapeutics reported Capital Expenditures of $1.17 million, up 8.1% year-over-year; for FY2025, it was $1.19 million, down 48.6% from FY2024.
- Capital Expenditures carries a four-year compound annual growth rate of 9.1% (FY2021 to FY2025).
- Going back by year, Capital Expenditures was $2.32 million in FY2024 (-72.8%), $8.52 million in FY2023 (+70.9%), $4.99 million in FY2022 (+494.2%) and $839,000 in FY2021.
- The five-year range for quarterly Capital Expenditures is -$65,000 (Q4 2024) to $2.48 million (Q2 2023).
- Year-over-year, Capital Expenditures increased in 1 of the last six quarters, with an average decline of 30.0%.
- The fastest year-over-year change in Capital Expenditures over five years came in Q3 2021 (growth of 152.3%), and the weakest in Q1 2024 (a decline of 86.7%).
- Business Quant data shows GYRE's Capital Expenditures at $178,000 (Q1 2026), $144,000 (Q4 2025) and $589,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -321.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -763.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Gyre Therapeutics | 753.90 Mn | 556.61 Mn | 26.90 Mn | 262,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 262,000.00 |
| Mar 31, 2026 | 178,000.00 |
| Dec 31, 2025 | 144,000.00 |
| Sep 30, 2025 | 589,000.00 |
| Jun 30, 2025 | 335,000.00 |
| Mar 31, 2025 | 122,000.00 |
| Dec 31, 2024 | -65,000.00 |
| Sep 30, 2024 | 693,000.00 |
| Jun 30, 2024 | 1.46 Mn |
| Mar 31, 2024 | 231,000.00 |
| Dec 31, 2023 | 2.32 Mn |
| Sep 30, 2023 | 1.97 Mn |
| Jun 30, 2023 | 2.48 Mn |
| Mar 31, 2023 | 1.74 Mn |
| Sep 30, 2021 | 492,000.00 |
| Sep 30, 2020 | 195,000.00 |
| Jun 30, 2020 | 16,000.00 |
| Mar 31, 2020 | 17,000.00 |
| Dec 31, 2019 | -1,000.00 |
| Sep 30, 2019 | 1,000.00 |
API Access
Gyre Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();